Literature DB >> 1503451

In vitro susceptibilities of Mycoplasma genitalium to antibiotics.

H Renaudin1, J G Tully, C Bebear.   

Abstract

The susceptibilities of seven clinical isolates of Mycoplasma genitalium and three strains of Mycoplasma pneumoniae to a variety of antibiotics were examined by an agar dilution method. Macrolides, pristinamycin, and tetracyclines were very active against both species. Sparfloxacin was the most active quinolone tested. None of the 21 antibiotics tested had differential activity toward the two organisms.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1503451      PMCID： PMC189472          DOI： 10.1128/AAC.36.4.870

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin.

Authors:  G E Kenny; F D Cartwright
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  The pathogenicity of a newly discovered human mycoplasma (strain G37) for the genital tract of marmosets.

Authors:  D Taylor-Robinson; P M Furr; C M Hetherington
Journal:  J Hyg (Lond)       Date:  1982-12

3.  DNA probes for detection and identification of Mycoplasma pneumoniae and Mycoplasma genitalium.

Authors:  H C Hyman; D Yogev; S Razin
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

4.  In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.

Authors:  K B Waites; L B Duffy; T Schmid; D Crabb; M S Pate; G H Cassell
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

5.  Probable insensitivity of mollicutes to rifampin and characterization of spiroplasmal DNA-dependent RNA polymerase.

Authors:  A P Gadeau; C Mouches; J M Bove
Journal:  J Bacteriol       Date:  1986-06       Impact factor: 3.490

6.  Serological cross-reactions between Mycoplasma genitalium and Mycoplasma pneumoniae.

Authors:  K Lind; B O Lindhardt; H J Schütten; J Blom; C Christiansen
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

7.  Urogenital mycoplasma infections of man: a review with observations on a recently discovered mycoplasma.

Authors:  D Taylor-Robinson; J G Tully; P M Furr; R M Cole; D L Rose; N F Hanna
Journal:  Isr J Med Sci       Date:  1981-07

8.  Prevalence of Mycoplasma genitalium determined by DNA probe in men with urethritis.

Authors:  T M Hooton; M C Roberts; P L Roberts; K K Holmes; W E Stamm; G E Kenny
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

9.  [Comparative activity of minocycline and doxycycline on mycoplasmas pathogenic for man].

Authors:  C Bebear; P Cantet; H Renaudin; C Quentin
Journal:  Pathol Biol (Paris)       Date:  1985-06

10.  Polymerase chain reaction for detection of Mycoplasma genitalium in clinical samples.

Authors:  J S Jensen; S A Uldum; J Søndergård-Andersen; J Vuust; K Lind
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948
View more
  12 in total

1.  Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR.

Authors:  Ryoichi Hamasuna; Yukio Osada; Jørgen Skov Jensen
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 2.  Mycoplasma genitalium: from Chrysalis to multicolored butterfly.

Authors:  David Taylor-Robinson; Jørgen Skov Jensen
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 3.  New Horizons in Mycoplasma genitalium Treatment.

Authors:  Catriona S Bradshaw; Jorgen S Jensen; Ken B Waites
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

4.  Mycoplasma genitalium: should we treat and how?

Authors:  Lisa E Manhart; Jennifer M Broad; Matthew R Golden
Journal:  Clin Infect Dis       Date:  2011-12       Impact factor: 9.079

5.  In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae.

Authors:  K Ishida; M Kaku; K Irifune; R Mizukane; H Takemura; R Yoshida; H Tanaka; T Usui; N Suyama; K Tomono
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

6.  Mycoplasma genitalium in the joints of two patients with arthritis.

Authors:  D Taylor-Robinson; C B Gilroy; S Horowitz; J Horowitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

7.  Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection.

Authors:  Tim R H Read; Jørgen S Jensen; Christopher K Fairley; Mieken Grant; Jennifer A Danielewski; Jenny Su; Gerald L Murray; Eric P F Chow; Karen Worthington; Suzanne M Garland; Sepehr N Tabrizi; Catriona S Bradshaw
Journal:  Emerg Infect Dis       Date:  2018-02       Impact factor: 6.883

Review 8.  Mycoplasma genitalium: an emerging sexually transmitted pathogen.

Authors:  Sunil Sethi; Gagandeep Singh; Palash Samanta; Meera Sharma
Journal:  Indian J Med Res       Date:  2012-12       Impact factor: 2.375

Review 9.  Management of Mycoplasma genitalium infections - can we hit a moving target?

Authors:  Jørgen Skov Jensen; Catriona Bradshaw
Journal:  BMC Infect Dis       Date:  2015-08-19       Impact factor: 3.090

10.  Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin.

Authors:  Alexander Guschin; Pavel Ryzhikh; Tatiana Rumyantseva; Mikhail Gomberg; Magnus Unemo
Journal:  BMC Infect Dis       Date:  2015-02-03       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.